1 / 19

GMP Compliance Trends: An Industry Perspective

GMP Compliance Trends: An Industry Perspective. Mitchell W. Manning Priorities Limited manningmitch@aol.com. GMP Compliance Trends: An Industry Perspective. Presentation Context: Current Compliance Issues for Pharmaceuticals and Devices Presentation Sources: FDA.gov - Wall Street Journal

derex
Download Presentation

GMP Compliance Trends: An Industry Perspective

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GMP Compliance Trends: An Industry Perspective Mitchell W. Manning Priorities Limited manningmitch@aol.com

  2. GMP Compliance Trends: An Industry Perspective Presentation Context: Current Compliance Issues for Pharmaceuticals and Devices Presentation Sources: • FDA.gov - Wall Street Journal • ASQ - Fortune • ISPE - Harvard Business Review • PDA - Burrill & Company • Internet - Interviews Presentation Disclaimer: The information and opinions expressed by the presenter are intended for general training and educational use of the conference audience and are not intended as official positions of the ASQ/FDC-FDA.

  3. GMP Compliance Trends: An Industry Perspective Trend One: GMP Compliant Manufacturing by Design Trend Two: Partnering With the Regulators Trend Three: Outsourcing Compliance Leadership Trend Four: Risk Management of Compliance Trend Five: Compliance through PAT Trend Six: Multiple Compliance Requirements Trend Seven: Going Global Trend Eight: Going High Tech Trend Nine: Risk Management of GMP Inspections Trend Ten: Over-committing and under-performing Trend Eleven: GMP Compliance to GMP Quality Trend Twelve: Risk Taking before Risk Management Trend Thirteen: Rx GMPs preferred over Dx GMPs

  4. GMP Compliance Trends: An Industry Perspective Trend One: GMP Compliant Manufacturing by Design

  5. Integrated Quality System Continuous Improvement Design Execute Monitor/Control Design – determine what is really important Execute – translate into manufacturing Monitor/Control – translate into quality assurance

  6. Process Control and Capability Cycle Development History Integrated Validation Master Plan process product systems • Begin with the End in Mind • Compliant • Capable • Robust • In Control • Continuously Improving Establish shared standards and expectations Process Flow Document Technology Transfer Qualification • Document with GMPs in Mind • Clear • Concise • Correct • Complete • Confident Execute and monitor with best business practices. Validation process and product Execute, Monitor and Control Technical Evaluations process and product Quality (GMP) Evaluations quality systems Change Control process and product Change Control quality systems Assess results against the standards and practices. Quality Management System

  7. GMP Compliance Trends: An Industry Perspective Trend Two: Partnering with the Regulators Drug Pipeline Globalization Bioterrorism Counterfeit Drugs and Devices Pandemics GMP Complexity Personalized Medicine

  8. Burrill's Predictions for Biotech in 2006 http://www.bcbiotech.ca/BIO_Links/Issue4/In_the_Media/Burrill_12_22_05.asp Biotechnology will continue to fuel a major transformation in healthcare -- one that emphasizes earlier disease detection, more targeted treatments, and adjunctive support through enhanced nutrition. A reasonably robust public equity IPO market -- 30+ in the U.S. in 2006 and even a larger number internationally. More pricing pressure -- managed care, CMS, various country health ministries The trend towards Mergers and Acquisitions will continue with substantially more deals than 2005, especially among the larger companies. Similarly, we will see more and larger partnering deals with an emphasis towards discovery stage deals. Drug safety issues will be high on the agenda and approvals will be tougher to obtain. The trend towards personalized medicine will accelerate.

  9. GMP Compliance Trends: An Industry Perspective Trend Three: Outsourcing Compliance Leadership

  10. GMP Compliance Trends: An Industry Perspective Trend Four: Risk Management of Compliance

  11. GMP Compliance Trends: An Industry Perspective Trend Five: Compliance through PAT

  12. GMP Compliance Trends: An Industry Perspective Trend Six: Multiple Compliance Requirements

  13. GMP Compliance Trends: An Industry Perspective Trend Seven: Going Global

  14. GMP Compliance Trends: An Industry Perspective Trend Eight: Going High Tech

  15. GMP Compliance Trends: An Industry Perspective Trend Nine: Risk Management of GMP Inspections

  16. GMP Compliance Trends: An Industry Perspective Trend Ten: Over-committing and under-performing

  17. GMP Compliance Trends: An Industry Perspective Trend Eleven: GMP Compliance to GMP Quality

  18. GMP Compliance Trends: An Industry Perspective Trend Twelve: Risk Taking before Risk Management

  19. GMP Compliance Trends: An Industry Perspective Trend Thirteen: Rx GMPs preferred over Dx GMPs Globalization of Standards Coming together of Regulators and Industry Inspectorate Partnering Control Processes through Validation Skills Competency Validation Resolving Problems

More Related